MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$25,455K
Free Cash flow
$320,251K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Borrowings
Net income
Depreciation and amortization
Others
Negative Cash Flow Breakdown
Payments on long-term debt
Purchase of treasury stock from ...
Other purchases of treasury stoc...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income
343,223
275,035
331,031
240,249
Depreciation and amortization
167,808
177,829
186,703
177,490
Impairment charges
-
-
0
-
Loss on extinguishment of debt
-
-
8,133
4,253
Stock-based compensation expense
26,029
28,160
38,394
38,992
Deferred income taxes
-1,367
54,798
17,585
78,827
Equity investment loss, net
-2,467
30
-42,781
-43,802
Gain on changes in ownership interests
-
-
0
0
Other non-cash losses, net
-10,015
-6,706
29,071
-4,574
Accounts receivable
-5,554
29,751
65,944
-143,759
Inventories
8,962
-20,277
20,863
-10,505
Other current assets
35,567
22,772
-29,131
82,483
Other long-term assets
20,232
2,571
40,232
3,002
Accounts payable
31,413
-23,774
30,424
62,267
Accrued compensation and benefits
-19,979
-88,343
-43,321
144,644
Other current liabilities
41,066
-96,903
-46,425
20,048
Income taxes
-59,655
27,125
80,880
-40,097
Other long-term liabilities
8,256
-4,955
21,520
-2,299
Net cash provided by operating activities
490,069
320,831
540,726
841,529
Additions of property and equipment
169,818
102,018
145,430
166,085
Acquisitions
4,616
33,924
-869
107,741
Proceeds from asset and business sales
671
3,721
1,836
9,937
Purchase of debt investments held-to-maturity
8
290
563
-11,633
Purchase of other debt and equity investments
3,212
9,655
2,679
350
Proceeds from debt investments held-to-maturity
0
942
7,362
-9,963
Proceeds from sale of other debt and equity investments
50
4,332
17
327
Purchase of equity method investments
17,317
2,308
24,564
322
Distributions from equity method investments
0
109
26
44
Net cash used in investing activities
-194,250
-139,091
-163,126
-262,520
Borrowings
1,505,080
1,263,179
940,110
482,454
Payments on long-term debt
1,347,269
917,087
908,124
507,421
Deferred and debt related financing costs
1,763
2,882
27,403
26,416
Purchase of treasury stock from related party
182,865
199,940
54,347
230,025
Other purchases of treasury stock
181,481
196,371
274,479
240,053
Distributions to noncontrolling interests
64,452
85,440
91,549
81,634
Net proceeds from issuance of common stock under employee stock plans
3,523
2,386
5,707
8,670
Payment of tax withholdings on net share settlements of equity awards
659
63,155
1,527
3,287
Contributions from noncontrolling interests
190
4,049
3,079
1,421
Proceeds from sales of additional noncontrolling interests
0
-
3,625
0
Purchases of noncontrolling interests
489
18,082
9,613
11,007
Net cash used in financing activities
-270,185
-213,343
-414,521
-582,165
Effect of exchange rate changes on cash, cash equivalents and restricted cash
-179
259
-746
1,611
Net decrease in cash, cash equivalents and restricted cash
25,455
-31,344
-37,667
-1,545
Cash, cash equivalents and restricted cash at beginning of the year
726,403
757,747
524,573
524,573
Cash, cash equivalents and restricted cash at end of the period
751,858
726,403
757,747
795,414
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net income
$343,223K
(24.71%↑ Y/Y)
Depreciation and
amortization
$167,808K
(-3.95%↓ Y/Y)
Other current
liabilities
$41,066K
(14.68%↑ Y/Y)
Accounts payable
$31,413K
(396.83%↑ Y/Y)
Stock-based compensation
expense
$26,029K
(-20.66%↓ Y/Y)
Other non-cash
losses, net
-$10,015K
(-5398.94%↓ Y/Y)
Other long-term
liabilities
$8,256K
(691.83%↑ Y/Y)
Accounts receivable
-$5,554K
(-104.17%↓ Y/Y)
Equity investment
loss, net
-$2,467K
(91.02%↑ Y/Y)
Net cash provided by
operating activities
$490,069K
(51.15%↑ Y/Y)
Canceled cashflow
$145,762K
Net decrease in
cash, cash...
$25,455K
(-90.65%↓ Y/Y)
Canceled cashflow
$464,614K
Income taxes
-$59,655K
(-96.45%↓ Y/Y)
Other current assets
$35,567K
(19.12%↑ Y/Y)
Other long-term
assets
$20,232K
(101.41%↑ Y/Y)
Accrued compensation
and benefits
-$19,979K
(-806.22%↓ Y/Y)
Inventories
$8,962K
(273.01%↑ Y/Y)
Deferred income taxes
-$1,367K
(90.35%↑ Y/Y)
Borrowings
$1,505,080K
(-57.68%↓ Y/Y)
Net proceeds from
issuance of common stock...
$3,523K
(-11.39%↓ Y/Y)
Contributions from
noncontrolling interests
$190K
(-53.55%↓ Y/Y)
Proceeds from asset and
business sales
$671K
(-94.28%↓ Y/Y)
Proceeds from sale of
other debt and equity...
$50K
(-93.03%↓ Y/Y)
Net cash used in
financing activities
-$270,185K
(-6177.04%↓ Y/Y)
Net cash used in
investing activities
-$194,250K
(-189.21%↓ Y/Y)
Effect of exchange rate
changes on cash, cash...
-$179K
(-101.65%↓ Y/Y)
Canceled cashflow
$1,508,793K
Canceled cashflow
$721K
Payments on long-term
debt
$1,347,269K
(-55.50%↓ Y/Y)
Additions of property and
equipment
$169,818K
(40.24%↑ Y/Y)
Purchase of equity method
investments
$17,317K
(707.70%↑ Y/Y)
Acquisitions
$4,616K
(1207.65%↑ Y/Y)
Purchase of other debt and
equity investments
$3,212K
(504.90%↑ Y/Y)
Purchase of treasury
stock from related...
$182,865K
(8.48%↑ Y/Y)
Other purchases of
treasury stock
$181,481K
(-36.02%↓ Y/Y)
Distributions to
noncontrolling interests
$64,452K
(11.00%↑ Y/Y)
Deferred and debt related
financing costs
$1,763K
(-90.58%↓ Y/Y)
Payment of tax
withholdings on net share...
$659K
(150.57%↑ Y/Y)
Purchases of
noncontrolling interests
$489K
Purchase of debt
investments...
$8K
(-98.62%↓ Y/Y)
Buy us a coffee
Davita_Kidney_Care-svg
DAVITA INC. (DVA)
Davita_Kidney_Care-svg
DAVITA INC. (DVA)